SG Americas Securities’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15K | Sell |
|
|||||
|
2025
Q2 | $13K | Sell |
|
|||||
|
2025
Q1 | $31K | Buy |
|
|||||
|
2024
Q4 | $41K | Buy |
|
|||||
|
2024
Q3 | $72K | Buy |
|
|||||
|
2024
Q2 | $37K | Buy |
|
|||||
|
2024
Q1 | $46K | Sell |
|
|||||
|
2023
Q4 | $67K | Sell |
|
|||||
|
2023
Q3 | $64K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $92K | Buy |
|
|||||
|
2022
Q4 | $48K | Sell |
|
|||||
|
2022
Q3 | $83K | Sell |
|
|||||
|
2022
Q2 | $66K | Buy |
|
|||||
|
2022
Q1 | $70K | Buy |
|
|||||
|
2021
Q4 | $78K | Sell |
|
|||||
|
2021
Q3 | $289K | Sell |
|
|||||
|
2021
Q2 | $385K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $68K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $44K | Buy |
|
|||||
|
2020
Q1 | $32K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $206K | Buy |
|
|||||
|
2017
Q2 | $222K | Sell |
|
|||||
|
2017
Q1 | $205K | Sell |
|
|||||
|
2016
Q4 | $543K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $139K | Buy |
|
|||||
|
2015
Q4 | $101K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $59K | Sell |
|
|||||
|
2014
Q3 | $147K | Buy |
|
|||||
|
2014
Q2 | $72K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $86K | Sell |
|
|||||
|
2013
Q3 | $116K | Buy |
|
|||||
|
2013
Q2 | $60K | Buy |
|